The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
Código de la empresaTOIIW
Nombre de la empresaOncology Institute Inc
Fecha de salida a bolsaMar 13, 2020
Fundada en2019
Director ejecutivoDr. Daniel Virnich, M.D.
Número de empleados- -
Tipo de títulosCompany Warrant
Fin del año fiscal- -
Dirección18000 Studebaker Rd
CiudadCERRITOS
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal90703
Teléfono15627353226
Sitio Webhttps://theoncologyinstitute.com/
Código de la empresaTOIIW
Fecha de salida a bolsaMar 13, 2020
Fundada en2019
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

No datos encontrados